# Efficacy and safety of adalimumab in Japanese patients with moderately to severely active ulcerative colitis

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-adalimumab-in-japanese-patients-with-moderately-to/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yasuo Suzuki,Satoshi Motoya,Hiroyuki Hanai,Takayuki Matsumoto,Toshifumi Hibi∥,Anne Robinson,Nael M. Mostafa,Jingdong Chao,Vipin Arora,Anne Camez,Roopal Thakkar,Mamoru Watanabe |
| Citations | 166 |
| DOI | 10.1007/s00535-013-0922-y |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s00535-013-0922-y.pdf |
| OpenAlex ID | https://openalex.org/W2062766962 |
| PMID | 24363029 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Jingdong Chao](https://scholariq.org/researchers/jingdong-chao/)

## Paper primary topic

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)

## Paper topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.